Esophageal cancer is a rare form of cancer, accounting for roughly one percent of all cancer diagnoses in the United States each year. The timing of a diagnosis is the single most important factor in a patient's prognosis: When caught early, about half of patients survive five years or more; when detected late, that rate drops drastically. By helping us catch this cancer sooner and treat it more effectively, your gift can close that critical gap.
Less common cancers often struggle to secure research funding compared to better-known diseases, making your support especially vital. Gifts to the Esophageal Cancer Research Fund power critical research at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center—Indiana's only National Cancer Institute-designated comprehensive cancer center. Here, researchers lead innovative clinical trials, giving patients access to promising new treatments before they are widely available elsewhere.
The donors who established this fund intended to accelerate esophageal cancer research at the Indiana University School of Medicine. Your gift works directly alongside theirs to carry that mission forward. Thank you for your generosity.
Please note, the name and purpose of the fund displayed on this page constitute the authorized description of the fund by the Indiana University Foundation, Inc. Your gift supports the fund as described herein.
Gifts will be administered by the Indiana University Foundation, Inc. which represents Indiana University, including the IU School of Medicine. This is not a gift to Indiana University Health, and the Indiana University Health Foundation will not play a role in administering these accounts.